---
stage_id: "02"
reviewer_id: "spec-driving-reviewer"
artifact_path: "artifacts/02_mvp_scope_decision_v1.md"
verdict: "PASS"
iteration: 1
reviewed_at: "2026-06-09"
---

# Review - Stage 02

## Verdict

PASS

Stage 02 toma una decisión clara de MVP, separa Fase 1/Fase 2/fuera de alcance y deja un handoff suficiente para Stage 03 sin inventar alcance ni saltarse restricciones.

## Reviewed Artifact

`artifacts/02_mvp_scope_decision_v1.md`

## Checklist Evidence

| Criterion | Evidence | Result |
| --- | --- | --- |
| Artifact path and name are correct | Artifact exists at `artifacts/02_mvp_scope_decision_v1.md`. | PASS |
| Required sections are present | Includes Decision Summary, Phase 1 / MVP Scope, Phase 2 Candidates, Explicitly Out of Scope, Rationale, Dependency Notes, Risk Notes, Unresolved Questions, Do Not Sell This Yet Warnings, and Handoff to Next Stage. | PASS |
| Stage makes a decision | Decision Summary explicitly defines Fase 1 as portal cliente + Odoo + web/pago + procesos/informe + automatizaciones operativas, with TellmeGen external. | PASS |
| Phase 1 scope is explicit | Phase 1 lists workshop, tool validation, portal cliente, Odoo, web/pago integration, portal->Odoo states, informe final, automations, security/minimization, documentation/training/support. | PASS |
| Phase 2 candidates are explicit | Phase 2 includes TellmeGen API future, old API budget, alternate lab API, advanced report automation, genetic dashboard, BI and productization. | PASS |
| Out of scope is explicit | Excludes TellmeGen API, barcode/user/test automation, genetic dashboard, automatic interpretation, own platform/app, legal guarantees and Stage 06 execution plan. | PASS |
| Rationale is grounded in previous stages | Rationale cites Carmen's practical/acotada request and Aitor's operational pain from Stage 00/01 with source ids. | PASS |
| Buyer priority is respected | Carmen is prioritized for scope, Aitor for operational pain, Tomás only for ROI/cost/value. | PASS |
| No unsupported assumptions hidden | Unknowns are listed as dependencies and unresolved questions instead of being treated as closed. | PASS |
| No scope creep | The artifact does not create blueprint, proposal, execution plan, backlog, milestones, repo structure or ROI artifact. | PASS |
| No contradiction with Stage 01 | Preserves the Stage 01 conclusion that TellmeGen API is not resoluble in Fase 1. | PASS |
| Do-not-sell warnings exist | Includes specific warnings not to sell TellmeGen integration, automatic genetics, closed ROI, Healthie/Odoo certainty, legal guarantees or execution plan. | PASS |
| Handoff exists | Handoff tells Stage 03 what to blueprint and what not to reintroduce. | PASS |

## Missing Items

- No blocking missing item for Stage 02.
- Stage 03 still needs to handle unresolved dependencies: Healthie/ContinuousCare validation, Odoo state, web/pago integration contract, report process, legal/DPO, volume and hours.

## Contradictions

- The artifact resolves the main contradiction for scope: TellmeGen API was requested initially but is excluded from Fase 1 because current evidence says no API exists.
- Healthie preference remains conditional, correctly preserving the uncertainty from Stage 00/01.

## Scope Creep

No scope creep detected. Stage 02 does not generate Stage 03 blueprint, Stage 04 proposal or Stage 06 execution plan.

## Unsupported Assumptions

No unsupported assumption is presented as fact. Healthie, Odoo readiness, web/pago integration and ROI are all conditional.

## Required Fixes

None required before Stage 03.

## Shortest Fix Path

No fix required. Advance to Stage 03: Technical Pre-Sales Blueprint.

## Blocking Questions

None for Stage 02.
